Mometasone Target (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Target, is a corticosteroid presented as a nasal spray formulation for nasal use. It is employed to treat allergic rhinitis and nasal polyps in both adult and pediatric patients.

GNH USA supplies Mometasone Target as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone Target is a topical corticosteroid that acts on inflammatory processes of the nasal mucosa.

Allergic rhinitis (seasonal): reduces nasal congestion, sneezing and itching associated with seasonal allergens. Allergic rhinitis (perennial): alleviates chronic nasal symptoms caused by year‑round allergens. Nasal polyps: decreases polyp size and improves airflow through the nasal passages.

Mometasone Target may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Sore throat - Cough - Altered taste or smell

Serious or Rare Side Effects: - Nasal septal perforation - Severe or prolonged epistaxis - Adrenal suppression with long‑term use - Vision changes such as cataracts or glaucoma - Opportunistic fungal infection of the nasal cavity - Systemic corticosteroid effects (e.g., hyperglycemia)

Before using Mometasone Target, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Local infection: avoid use if active nasal infection is present. Surgery: inform the surgeon of nasal corticosteroid use. Long‑term therapy: monitor for signs of adrenal suppression. Use only as directed: do not exceed the prescribed dose or frequency. Store at room temperature: keep in the original container, protect from moisture and light.

Mometasone Target can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: additive effect on nasal dryness. - Anticholinergic nasal sprays: may increase local irritation. - Live vaccines: consider timing of administration relative to nasal steroid use.